Nektar Therapeutics | صافي الدخل



Net Income تغيير تاريخ
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
ALKERMES USD 22.46M 344.61M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Baxter International USD 126M 638M 2025-03
Biogen USD 240.5M 26.2M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Cipla INR 12.22B 3.49B 2025-03
Dr.Reddys Laboratories INR 15.87B 1.73B 2025-03
Eisai JPY 949M 22.84B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Exelixis USD 159.62M 19.76M 2025-04
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Grifols EUR 68.97M 17.28M 2024-12
Halozyme Therapeutics USD 118.1M 18.92M 2025-03
Incyte USD 158.2M 43.01M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
MacroGenics USD -15421000 71.73M 2024-12
Merck USD 5.08B 1.34B 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Takeda JPY -103155000000 126.94B 2025-03
Teva Pharmaceutical Industries USD 214M 431M 2025-03
Xencor USD -48418000 5.06M 2025-03



Nektar Therapeutics صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.